Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.

MLA

Calfee, D. P., et al. “Safety and Efficacy of Intravenous Zanamivir in Preventing Experimental Human Influenza A Virus Infection.” Antimicrobial Agents and Chemotherapy, vol. 43, no. 7, July 1999, pp. 1616–20. EBSCOhost, https://doi.org/10.1128/AAC.43.7.1616.

APA

Calfee, D. P., Peng, A. W., Cass, L. M., Lobo, M., & Hayden, F. G. (1999). Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection. Antimicrobial Agents and Chemotherapy, 43(7), 1616–1620. https://doi.org/10.1128/AAC.43.7.1616

Chicago

Calfee, D P, A W Peng, L M Cass, M Lobo, and F G Hayden. 1999. “Safety and Efficacy of Intravenous Zanamivir in Preventing Experimental Human Influenza A Virus Infection.” Antimicrobial Agents and Chemotherapy 43 (7): 1616–20. doi:10.1128/AAC.43.7.1616.